plx4032 in metastatic colorectal cancer patients with mutant braf tumors
DESCRIPTION
PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors. Scott Kopetz 1 , Jayesh Desai 2 , Emily Chan 3 , J Randolph Hecht 4 , Peter J O’Dwyer 5 , Richard J Lee 6 , Keith B Nolop 7 , Suman Bhattacharya 8 , Leonard Saltz 9 - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/1.jpg)
PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors
Scott Kopetz1, Jayesh Desai2, Emily Chan3, J Randolph Hecht4 , Peter J O’Dwyer5, Richard J Lee6, Keith B Nolop7, Suman Bhattacharya8, Leonard Saltz9
1 The University of Texas M.D. Anderson Cancer Center, Houston, TX; 2 Royal Melbourne Hospital, Parkville, Australia;
3 Vanderbilt-Ingram Cancer Center, Nashville, TN; 4 David Geffen School of Medicine at UCLA, Los Angeles, CA;
5 Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA; 6 Roche, Nutley, NJ;
7 Plexxikon, Berkeley, CA; 8 Genentech, Inc., South San Francisco, CA;
9 Memorial Sloan-Kettering Cancer Center, New York, NY
![Page 2: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/2.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 3: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/3.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 4: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/4.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 5: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/5.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 6: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/6.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 7: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/7.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 8: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/8.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 9: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/9.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 10: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/10.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 11: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/11.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 12: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/12.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 13: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/13.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 14: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/14.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534
![Page 15: PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors](https://reader035.vdocuments.net/reader035/viewer/2022081512/5681613c550346895dd09e82/html5/thumbnails/15.jpg)
Kopetz, Desai, et al ASCO 2010 Abs# 3534